Search

23 Feb 2023: It is great news that Cyto-Mine and our single cell analysis technology has been recognised by the broader UK business community as revolutionary. ... Dr Rob Marchmont. Dr Rob Marchmont, Fluidic’s Commerical Director, attended the awards ceremony and

22 Feb 2023: Paragraf, the graphene technology development company, a recent spin out from the University of Cambridge, has closed a £2.9 million seed round...

23 Feb 2023: Evotec AG has announced an integrated drug discovery collaboration with STORM Therapeutics to develop new small molecule epigenetic drugs.

22 Feb 2023: The new spin-out company will translate cutting-edge cell biology research on DNA repair from Professor Jackson’s laboratory into new drugs. Read more here.

23 Feb 2023: The award, from Global University Venturing, was in recognition of the work Cambridge Enterprise does in support of new companies. Read more here.

23 Feb 2023: Versed AI, which uses NLP to automatically map supply chains, has won the £20,000 first prize in the 2019 Postdoc Business Plan Competition.

21 Mar 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 20 March 2023. The economic impact of the University of Cambridge. Share:. The University contributes nearly £30 billion to the UK economy and supports more than 86,000 jobs across

22 Feb 2023: PredictImmune, a developer of prognostic tools to guide treatment of patients with immune-mediated diseases, announced today that it has been awarded £4.3m...

22 Feb 2023: Cambridge spin-out company Paragraf has started producing graphene—a sheet of carbon just one atomic layer thick—at up to eight inches in diameter, large enough for commercial electronic devices. Paragraf is producing graphene ‘wafers’ and

22 Feb 2023: One year after seeding Carrick Therapeutics, Cambridge Enterprise has joined in a $95m funding.

22 Feb 2023: Cambridge Enterprise portfolio company PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, today...

4 Apr 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 31 March 2023. Wound care company NoBACZ Healthcare Ltd announces £2.7m seed round. Share:. Cambridge Enterprise portfolio company NoBACZ Healthcare Ltd closes £2.7m seed round to

23 Feb 2023: The Fund has made a seed investment in Sphere Fluidics, which was formed earlier this month. Read more here.

23 Feb 2023: Responsible for the commercialisation of University research, Cambridge Enterprise recently announced its results for the 2010 financial year.

13 Oct 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 13 October 2023. Strategy unveiled at summit to boost innovation in Cambridge. Share:. An ambitious new strategy to nurture and grow the innovation ecosystem in Cambridge was unveiled

22 Feb 2023: Mobile menu. Mobile menu. Search. back. back. back. back. back. 9 November 2022. Kalium Health announces expansion to advance blood monitoring technology. Share:. Kalium Health Ltd, which aims to transform the way that kidney disease and heart

22 Feb 2023: Cambridge spin-out Poro Technologies raises £1.5m to develop a pilot Gallium Nitride (GaN) plant and its first major products.

22 Feb 2023: AudioTelligence, the company dedicated to making speech clear and intelligible in a noisy world, closes a $8.5m Series A funding round. 

22 Feb 2023: PredictImmune, developers of pioneering prognostic tools for guiding treatment options and improving patient outcomes in immune-mediated diseases, announced today the granting of...

22 Feb 2023: Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease...

22 Feb 2023: Cambridge Touch Technologies, a leading developer of AI-driven, 3D multi-touch sensing technologies for smart devices, has announced the completion of a $5.5m Series A1 round of investment.

22 Feb 2023: Inotec AMD, a maker of mobile medical devices designed to heal chronic, hypoxic wounds, secures investment from Amadeus Capital Partners.

23 Feb 2023: The fund will enable alumni and friends of the University to support the development of Cambridge spin-outs, while benefitting from generous tax incentives.